The groundbreaking success of Sildenafil undeniably revolutionized the medication landscape, but betting in companies primarily reliant on off-patent versions presents a complex picture. While early earnings were substantial, the expiration of patents and the emergence of less expensive alternatives have weakened market share. Consequently, a th… Read More